Antioxidant-rich diet relieves hypertension and reduces renal immune infiltration in spontaneously hypertensive rats

Hypertension

Volumn 41, Issue 2, 2003, Pages 341-346

  Rodriguez Iturbe, Bernardo ^a   Zhan, Chang De ^b   Quiroz, Yasmir ^a   Sindhu, Ram K ^b   Vaziri, Nosratola D ^b  

^a UNIVERSIDAD DEL ZULIA   (Venezuela)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antioxidants; Immune systems; Kidney; Lymphocytes; Macrophages; Rats, spontaneously hypertensive

Indexed keywords

3 NITROTYROSINE; ANGIOTENSIN; ANTIOXIDANT; HYDROGEN PEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DIET; FEMALE; GLOMERULUS FILTRATION; HYPERTENSION; INFLAMMATION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE;

ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; BLOOD PRESSURE; DIET; FEMALE; HYDROGEN PEROXIDE; HYPERTENSION; KIDNEY; KIDNEY GLOMERULUS; LYMPHOCYTES; MACROPHAGES; MALE; MALONDIALDEHYDE; PREGNANCY; RATS; RATS, INBRED SHR; RATS, INBRED WKY; VITAMIN E;

EID: 0037315499     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000052833.20759.64     Document Type: Article

References (47)

1. Berry C, Brosnan MJ, Fennell J, Hamilton CA, Dominiczak AF. Oxidative stress and vascular damage in hypertension. Curr Opin Nephrol Hypertens. 2001;2001:10:247-255.
2. Dhalla NS, Temsah RM, Netticadan T. Role of oxidative stress in cardiovascular diseases. J Hypertens. 2000;18:655-673.
3. Schnackenberg CG. Physiological and pathophysiological roles of oxygen radicals in the renal microvasculature. Am J Physiol (Regulatory Physiol). 2002;282:R335-R342.
4. Wilcox CS. Reactive oxygen species: roles in blood pressure and kidney function. Curr Hypertens Rep. 2002;4:160-166.
5. Barton CH, Ni Z, Vaziri ND. Enhanced nitric oxide inactivation in aortic coarctation-induced hypertension. Kidney Int. 2001;60:1083-1087.
6. Makino A, Skelton MM, Zou AP, Roman RJ, Cowley AW Jr. Increased renal medullary oxidative stress produces hypertension. Hypertension. 2002;39:667-672.
7. Zhou XJ, Vaziri ND, Wang XQ, Silva FG, Laszik Z. Nitric oxide synthase expression in hypertension induced by inhibition of glutathione synthase. J Pharmacol Exp Ther. 2002;300:762-767.
8. Vaziri ND, Wang XQ, Oveisi F, Rad B. Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. Hypertension. 2000;36:142-146.
9. Vaziri ND, Liang K, Ding Y. Increased nitric oxide inactivation by reactive oxygen species in lead-induced hypertension. Kidney Int. 1999;56:1492-1498.
10. Vaziri ND, Ni Z, Oviesi F, Liang K, Pandian R. Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency. Hypertension. 2002;39:135-141.
11. Roberts CK, Vaziri ND, Wang XQ, Barnard RJ. Enhanced NO inactivation induced by a high fat, refined-carbohydrate diet. Hypertension. 2000;36:423-429.
12. El Midaoui A, de Champlain J. Prevention of hypertension, insulin resistance, and oxidative stress by alpha-lipoic acid. Hypertension. 2002;39:303.307.
13. Park JB, Touyz RM, Chen X, Schiffrin EL. Chronic treatment with a superoxide dismutase mimetic prevents remodeling and progression of hypertension in salt-loaded stroke-prone spontaneously hypertensive rats. Am J Hypertens. 2002;15:78-84.
14. Schnackenberg CG, Welch WJ, Wilcox CS. Normalization of blood pressure and renal vascular resistance in SHR with a membrane permeable superoxide dismutase mimetic: Role of nitric oxide. Hypertension. 1998;32:59-64.
15. Schnackenberg CG, Wilcox CS. Two-week administration of tempol attenuates both hypertension and renal excretion of 8-iso prostaglandin f2 alpha. Hypertension. 1999;33:424-428.
16. Wu R, Lamontagne D, de Champlain J. Antioxidative properties of acetylsalicylic acid on vascular tissues from normotensive and spontaneously hypertensive rats. Circulation. 2002;105:387-392.
17. Noguchi T, Ikeda K, Sasaki Y, Yamamoto J, Seki J, Yamagata K, Nara I, Hara H, Kakuta H, Yamori Y. Effects of vitamin E and sesamin on hypertension and cerebral thrombogenesis in stroke-prone spontaneously hypertensive rats. Hypertens Res. 2001;24:735-742.
18. Chen X, Touyz RM, Park JB, Schiffrin EL. Antioxidant effects of vitamin C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension. 2001;38:606-611.
19. Wilcox CS, Welch WJ. Oxidative stress: cause or consequence of hypertension. Exp Biol Med. 2001;226:619-620.
20. Cabassi A, Bouchard JF, Dumont EC, Girouard H, Le Jossec M, Lamontagne D, Besner JG, de Champlain J. Effect of antioxidant treatments on nitrate tolerance development in normotensive and hypertensive rats. J Hypertens. 2000;18:187-196.
21. Vaziri ND, Ding Y, Ni Z. Compensatory up-regulation of nitric oxide synthase isoforms in lead-induced hypertension: reversal by a superoxide dismutase mimetic drug. J Pharmacol Exp Ther. 2001;298:679-685.
22. Vaziri ND, Ni Z, Oveisi F, Trnavsky-Hobbs DL. Effect of antioxidant therapy on blood pressure and NO synthase expression in hypertensive rats. Hypertension. 2000;36:957-964.
23. Wassman S, Laufs U, Stamenkovic D, Linz W, Stasch JP, Ahlbory K, Rosen R, Bohm M, Nickenig G. Raloxifene improves endothelial dysfunction in hypertension by reduced oxidative stress and enhanced nitric oxide production. Circulation. 2002;105:2083-2091.
24. Carr A, Frei B. The role of natural antioxidants in preserving the biological activity of endothelium-derived nitric oxide. Free Radic Biol Med. 2000;28:1806-1814.
25. Zalba G, Beaumont J, San Jose G, Fortuno A, Fortuno MA, Diez J. Vascular oxidant stress: molecular mechanisms and pathophysiological implications. J Physiol Biochem. 2000;56:57-64.
26. Rathaus A, Bernheim J. Oxygen species in the microvascular environment: regulation of vascular tone and the development of hypertension. Nephrol Dial Transplant. 2002;17:216-221.
27. Rodríguez-Iturbe B, Pons H, Herrera-Acosta J, Johnson RJ. The role of immunocompetent cells in nonimmune renal disease. Kidney Int. 2001;59:1626-1640.
28. Rodríguez-Iturbe B, Quiroz Y, Herrera-Acosta J, Johnson RJ, Pons HA. The role of immune cells infiltrating the kidney in the pathogenesis of salt-sensitive hypertension. J Hypertens. 2002;20(suppl 3):S9-S14.
29. Rodríguez-Iturbe B, Pons H, Quiroz Y, Gordon K, Rincón J, Chávez M, Parra G, Hererra-Acosta J, Gómez-Garre D, Largo R, Egido J, Johnson RJ. Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure. Kidney Int. 2001;59:2222-2232.
30. Quiroz Y, Pons H, Gordon KL, Rincón J, Chávez M, Parra G, Herrera-Acosta J, Gómez-Garre D, Largo R, Egido J, Johnson RJ, Rodríguez-Iturbe B. Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition. Am J Physiol (Renal Physiol). 2001;281:F38-F47.
31. Rodríguez-Iturbe B, Quiroz Y, Nava M, Bonet L, Chávez M, Herrea-Acosta J, Johnson RJ, Pons H. Reduction of renal immune infiltration results in blood pressure control in genetically hypertensive rats. Am J Physiol (Renal Physiol). 2002;282:F191-F201.
32. Alvarez V, Quiroz Y, Nava M, Pons H, Rodríguez-Iturbe B. Renal infiltration of immune cells cause salt-sensitive hypertension following overload proteinuria. Am J Physiol Renal Physiol. 2002;283: F1132-F1141.
33. Franco M, Tapia E, Santamaria J, Zafra I, García-Torres R, Gordon K, Pons H, Rodríguez-Iturbe B, Johnson RJ, Herrera-Acosta J. Renal cortical vasoconstriction contributes to the development of salt-sensitive hypertension after angiotensin II exposure. J Am Soc Nephrol. 2001;12:2263-2271.
34. Johnson RJ, Herrera-Acosta J, Schreiner G, Rodríguez-Iturbe B. Subtle acquired renal injury as mechanism of salt-sensitive hypertension. N Engl J Med. 2002 346:913-923.
35. Gonick HC, Ding Y, Bondy SC, Ni Z, Vaziri ND. Lead-induced hypertension: interplay of nitric oxide and reactive oxygen species. Hypertension. 1997;30:1487-1492.
36. Raij L, Azar S, Keane W. Mesangial immune injury, hypertension and progressive damage in Dahl rats. Kidney Int. 1984;26:137-143.
37. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol. 1978;52:302-310.
38. Roberts CK, Vaziri ND, Liang K, Barnard JR. Reversibility of experimental syndrome X by dietary modification. Hypertension. 2001;37:1323-1328.
39. Swei A, Lacy F, De Lano FA, Schmidt-Schonbein GW. Oxidative stress in the Dahl salt-sensitive rat. Hypertension. 1997;30:1628-1633.
40. Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA, Harrison DG. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation. 1997;95:588-593.
41. Roggensack AM, Zhang Y, Davidge ST. Evidence for peroxynitrite formation in the vasculature of women with preeclampsia. Hypertension. 1999;33:83-89.
42. Higashi Y, Sasaki S, Nakagawa K, Matsura H, Oshima T, Chayama K. Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med. 2002;346:1954-1952.
43. Reddi AS, Bollineni JS. Selenium-deficient diet induces renal oxidative stress and injury via TGF-B in normal and diabetic rats. Kidney Int. 2001;59:1342-1353.
44. Sato M, Yanagisawa H, Nojima Y, Tamura J, Wada O. Zinc deficiency aggravates hypertension in spontaneously hypertensive rats: possible role of Cu/Zn-superoxide dismutase. Clin Exp Hypertens. 2002;24:355-370.
45. Barton CH, Ni Z, Vaziri ND. Enhanced nitric oxide inactivation in aortic coarctation-induced hypertension. Kidney Int. 2001;60:183-187.
46. Lum H, Roebuck KA. Oxidant stress and endothelial cell dysfunction. Am J Physiol (Cell Physiol). 2001;280:C719-C741.
47. Zhou XJ, Wang XQ, Vaziri ND. Association of renal injury with nitric oxide deficiency in aged spontaneously hypertensive rats: prevention by AT-1 receptor blockade. Kidney Int. 2002;62:914-921.